NO | Ngwaahịa | Enweghị ego | Akwukwo icho oru | Isi ihe ngosi | ||||
Nko | Isooma | Oge adịghị ọcha | * Max1 | Mmiri mmiri | ||||
1 | Fmoc-cys (acm) -Oh | 86060-81-3 | A na-anapu nkekọ | ≥99.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
2 | Fmoc-cys (mmt) -Oh | 177582-21-7 | A na-anapu nkekọ | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
3 | Fmoc-cys (4-allylbutterate) -Oh | / | A na-anapu nkekọ | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
4 | MPA (TRT) -Oh | 27144-18-9 | Ngwụcha usoro | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
5 | FMOC-TH (TBU) -OL | 189337-28-8 | Ocetraotide | ≥97.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
6 | FMOC-D-ARR (PBF) -OH | 187618-60-6 | Desmopressin | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
7 | Fmoc-gly-gly-oh | 35665-38-4-4 | Banirurudin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
8 | Fmoc-gly-gly-gly-oh | 170941-79-79 | Terlipressin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
9 | Fmoc-gly-gly-gly-gly-oh | / | Banirurudin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
10 | FMOC-Gly-ASP (TBU) -OH | / | Banirurudin | ≥99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
11 | Boc-Cys (Trt) -Oh | 21947-98-8 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
12 | BOC-Arg (PBF) -OH | 200124-22-7 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
13 | Boc-ala-oh | 15761-38-3 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
14 | BOC-D-PHE-oh | 18942-49-9 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
15 | Boc-gly-oh | 4530-20-5 | Ngwụcha usoro | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
16 | Boc-Lys (BOC) -OH.DCHA | 15098-69-8 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
17 | Boc-ser (tbu) -Oh | 7738-22-9 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
18 | BOC-THA (TBU) -OH | 13734-40-2 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
19 | BOC-D-ala-oh | 7764-95-6 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
20 | Boc-Met-Oh | 2488-15-5-5 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
21 | BOC-Tyr (TBU) -OH | 47375-34-8 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
22 | BOC-D-ARC (PDF) -OH | 187618-60-6 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
23 | Boc-ASP (OTBU) -OH.DCHA | 1913/12/8 | Ngwụcha usoro | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
24 | FMOC-homorg (PBF) -OH | 1159680-21-3 | Eptifbatide | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
25 | FMOC-ASP-OTBU | 129460-09-9-9 | Thymalfasan | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
26 | FMOC-Tyr (m) -Oh | 7718-72-7-4 | Carbetocin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
27 | FMOC-orN (BOC) -OH | 109425-55-0 | Acosiban Omnip profains Daptomycin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
28 | FMOC-D-Tyr (et) -Oh | 162502-65-0 | Acosiban | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
29 | FMOC-ASP (Oall) -OH | 146982-24-3 | Melanotan | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
30 | Ac-nle-oh | 15891-49-3 | Melanotan | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
31 | Fmoc-nle-oh | 77284-32-3 | Melanotan Avamanotide | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
32 | Ac-glu (otbu) -Oh | 84192-88-1 | Agigram Acetyl oclepeptide-3 | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
33 | AC-β-ala-ohncha | / | Acetyl tetrapupde-5 | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
34 | FMOC-ß-ALA-oh | 35737-10-1 | Acetyl tetrapupde-5 | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
35 | FMOC-STY (TBU) -OH | 122996-47-8 | Mkpaka | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
36 | Fmoc-thi-oh | 130309-35-25-2 | Mkpaka | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
37 | Fmoc-d-tic-oh | 130309-33-0 | Mkpaka | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
38 | Fmoc-oic-oh | 130309-37-7-4 | Mkpaka | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
39 | BOC-Sar-oh | 13734-36-6 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
40 | FMOC-Sar | 7718-70-2 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
41 | FMOC-Tyr (So3na) -Oh.h2o | 10686-37-3 | Okwukwe | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
42 | FMOC-D-ASP (OTBU) -OH | 112883-39-3 | Daptomycin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
43 | Ac-ser (tbu) -Oh | 77285-09-7 | Avamanotide | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
44 | Boc-homocys (Trt) -Oh | 201419-16-16-1 | Depreootide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
45 | Fmoc-homocys (trt) -Oh | 167015-23-8 | Depreootide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
46 | Fmoc-dab-oh | 161420-87-7 | Venom | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
* Max1 = Max amaghi
Ihe ndị ọzọ na-egosi:
- acetic acid: ≤0.02% (ngwaahịa niile)
- ethl acetate: ≤0.5% (ngwaahịa niile)
- mmanya: ≤0.5% (ngwaahịa niile)
- Max ma ama ama: FMOC-TRP (BOC) -OH (143824-78-6) ≤0.3%; Ndị ọzọ ≤0.2%